QuidelOrtho Corp (QDEL)
42.84
-1.15
(-2.61%)
USD |
NASDAQ |
May 17, 16:00
42.84
0.00 (0.00%)
After-Hours: 16:30
QuidelOrtho Revenue (Quarterly): 711.00M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 711.00M |
| December 31, 2023 | 742.60M |
| September 30, 2023 | 744.00M |
| June 30, 2023 | 665.10M |
| March 31, 2023 | 846.10M |
| December 31, 2022 | 866.50M |
| September 30, 2022 | 783.80M |
| June 30, 2022 | 613.40M |
| March 31, 2022 | 1.002B |
| December 31, 2021 | 636.90M |
| September 30, 2021 | 509.80M |
| June 30, 2021 | 176.60M |
| March 31, 2021 | 375.34M |
| December 31, 2020 | 809.20M |
| September 30, 2020 | 476.06M |
| June 30, 2020 | 201.75M |
| March 31, 2020 | 174.65M |
| December 31, 2019 | 152.18M |
| September 30, 2019 | 126.49M |
| June 30, 2019 | 108.25M |
| March 31, 2019 | 147.97M |
| December 31, 2018 | 132.59M |
| September 30, 2018 | 117.40M |
| June 30, 2018 | 103.16M |
| March 31, 2018 | 169.14M |
| Date | Value |
|---|---|
| December 31, 2017 | 114.89M |
| September 30, 2017 | 50.89M |
| June 30, 2017 | 38.27M |
| March 31, 2017 | 73.69M |
| December 31, 2016 | 52.81M |
| September 30, 2016 | 49.34M |
| June 30, 2016 | 39.13M |
| March 31, 2016 | 50.32M |
| December 31, 2015 | 52.41M |
| September 30, 2015 | 46.81M |
| June 30, 2015 | 35.20M |
| March 31, 2015 | 61.70M |
| December 31, 2014 | 63.95M |
| September 30, 2014 | 41.19M |
| June 30, 2014 | 31.49M |
| March 31, 2014 | 46.67M |
| December 31, 2013 | 52.08M |
| September 30, 2013 | 33.54M |
| June 30, 2013 | 29.71M |
| March 31, 2013 | 62.00M |
| December 31, 2012 | 53.92M |
| September 30, 2012 | 33.00M |
| June 30, 2012 | 30.86M |
| March 31, 2012 | 37.96M |
| December 31, 2011 | 38.39M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
108.25M
Minimum
Jun 2019
1.002B
Maximum
Mar 2022
536.10M
Average
625.15M
Median
Revenue (Quarterly) Benchmarks
| Abbott Laboratories | 9.964B |
| Becton Dickinson & Co | 5.045B |
| Boston Scientific Corp | 3.856B |
| Tenon Medical Inc | 0.808M |
| Perspective Therapeutics Inc | -5.239M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.706B |
| Total Expenses (Quarterly) | 702.50M |
| EPS Diluted (Quarterly) | -25.50 |
| Enterprise Value | 5.270B |
| Gross Profit Margin (Quarterly) | 46.71% |
| Profit Margin (Quarterly) | -239.9% |
| Earnings Yield | -61.60% |
| Operating Earnings Yield | 4.60% |
| Normalized Earnings Yield | -1.737 |